Home
AYUMI Pharmaceutical Corporation

AYUMI Pharmaceutical Cor... Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainayumi-pharma.com

Year Founded2015

Employees201 - 500

Annual Revenue$25M - $50M

AYUMI Pharmaceutical Corporation

AYUMI Pharmaceutical Corporation (including company regionals)

ayumi-pharma.com

See more website traffic and engagement information

AYUMI Pharmaceutical Corporation Revenue up to November 2025 is 25M - 50M

revenue generated by AYUMI Pharmaceutical Corporation top domains

AYUMI Pharmaceutical Corporation top domains revenue over 3 years

Revenue for AYUMI Pharmaceutical Corporation top domains

ayumi-pharma.com25M - 50M

See more with Sales Intelligence

Total visits to AYUMI Pharmaceutical Corporation's top domains

Understand AYUMI Pharmaceutical Corporation market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ayumi-pharma.com34.4K

See more with Sales Intelligence

Avg. visit duration in AYUMI Pharmaceutical Corporation's top domains

Analyze AYUMI Pharmaceutical Corporation engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ayumi-pharma.com00:01:53

See more with Sales Intelligence

Avg. pageviews on AYUMI Pharmaceutical Corporation's top domains

See how AYUMI Pharmaceutical Corporation keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ayumi-pharma.com2.23

See more with Sales Intelligence

AYUMI Pharmaceutical Corporation top competitors by domain

Top similar sites in November 2025, ranked by their affinity

ono-pharma.comCompany NameONO PHARMA UK LTDEmployees1001 - 5000HQJapan, OsakaAnnual revenue> $1BTotal visits45.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by AYUMI Pharmaceutical Corporation

These are the website technologies, by industry, used by AYUMI Pharmaceutical Corporation top domains

Email Services (2)

Microsoft Exchange Online

Payment & Currencies (2)

Israeli New Shekel

Advertising (1)

DoubleClick

Business Solutions (1)

DocuSign

More Technologies

4

See all

News & Signals from AYUMI Pharmaceutical Corporation

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAyumi Pharma launched high-dose 100mg/mL Adalimumab BS MA in Japan on Nov 25th '21.25 Nov 21 | JP | Mochida Pharmaceutical and Ayumi Pharmaceutical announced the launch of high-dose 100mg/mL Adalimumab BS MA ( adalimumab biosimilar) in Japan.

NewsBlackstone acquired Ayumi Pharma on Mar 15th '19.Blackstone (NYSE: BX) announced today that private equity funds managed by Blackstone (“Blackstone”) have entered into a definitive agreement to acquire AYUMI Pharmaceutical Corporation (“AYUMI” or “the Company”), a leading specialty pharmaceutical company in Japan focused on Anti-Rheumatism and Orthopedics, from Unison Capital, an independent private equity firm based in Japan, and M3, Inc., a medical information site business.